{"article":{"annotation":{"article_id":"brazil-hemobras-immunoglobulin-supply-agreement-october-2026","available_at":"2026-10-07T03:14:20.471008Z","geography_revision":"ef6ee0010dda5fe7b240fd514749b43e214c57da73222d2e40ec83b276dd0977","id":"cf5fb16c6f493a73de521a8b79e1c78af8a39e1cb7a4eb62cad8df3582b0f06a","input_sha256":"e75cc3cbd1d14a9b2081d5dbd4549b144ec237b42e13124544a14d0fd34deb2e","limitations":["Rule-derived subjects are candidates, not verified editorial labels or calibrated model probabilities.","Coverage is distinct from event location. Unknown country/city/coordinates remain absent; no automatic geocoding.","Article geometries keep their stated precision and methodology; reproducing them is not independent coordinate verification."],"method":"controlled-rules-v1","places":[{"admin1":null,"city":null,"coordinate_note":null,"coordinate_reference_system":"OGC:CRS84","coordinate_source":null,"country":"BR","evidence":[{"field":"country","language":"en","note":"Explicit preserved editorial country/region; no city or national centroid inferred","source_urls":["https://www.gov.br/saude/pt-br/assuntos/noticias-ms/2026/outubro/brasil-firma-acordo-para-ampliar-producao-de-imunoglobulina-medicamento-para-doencas-do-sangue/"]}],"geometry":null,"id":"iso3166-1:BR","kind":"country-or-area","labels":{"ar":"البرازيل","en":"Brazil","es":"Brasil","fr":"Brésil"},"match_status":"candidate","precision":"regional","role":"coverage","uncertainty_m":null}],"rules_sha256":"d28c9c89703b56bd91fd887965d416d0115c2473d4bfbd3e558bcceafc3941dd","schema_version":1,"subjects":[{"concept_id":"medtop:13000000","confidence":null,"confidence_method":null,"evidence":[{"field":"en.title+en.summary","language":"en","note":"Subject suggested from the title or summary: technology","source_urls":["https://www.gov.br/saude/pt-br/assuntos/noticias-ms/2026/outubro/brasil-firma-acordo-para-ampliar-producao-de-imunoglobulina-medicamento-para-doencas-do-sangue/"]}],"method":"controlled-rules-v1","rule_id":"technology","status":"candidate"},{"concept_id":"medtop:07000000","confidence":null,"confidence_method":null,"evidence":[{"field":"category+topics","language":"en","note":"Preserved editorial category/topic; broad candidate only","source_urls":["https://www.gov.br/saude/pt-br/assuntos/noticias-ms/2026/outubro/brasil-firma-acordo-para-ampliar-producao-de-imunoglobulina-medicamento-para-doencas-do-sangue/"]}],"method":"controlled-rules-v1","rule_id":"health-broad","status":"candidate"}],"taxonomy_revision":"1f2db31d811fca07e99b16d402c10e2cc2965c9df1c7b41d9be348b40a24e7fb","taxonomy_version":"IPTC Media Topics 2026-Q2"},"api_url":"https://newsverum.com/api/v1/articles/brazil-hemobras-immunoglobulin-supply-agreement-october-2026?lang=es","category":"health","content":{"key_points":[],"paragraphs":["El Ministerio de Salud de Brasil informó que Hemobrás y la empresa china Tiantan Bio firmaron un acuerdo de cooperación en São Paulo el 2 de octubre para ampliar las fuentes de suministro de inmunoglobulina. Según el ministerio, el acuerdo establece un marco para el registro en Brasil, el suministro de inmunoglobulina humana intravenosa y la concesión y transferencia de tecnología.","Los detalles del suministro y de la tecnología se definirán en acuerdos separados y estarán sujetos a los requisitos de Anvisa. El ministerio también dijo que la modernización de equipos podría aumentar cerca de un 30% la capacidad de almacenamiento de plasma; se distribuyeron 604 equipos a 125 servicios de hemoterapia y se asignaron 38 millones de reales para mejorar los centros de sangre."],"sections":[]},"corrections":[{"at":"2026-10-07T00:51:14+03:00","language":"es","text":"Se añadieron a este artículo las ediciones alemana y portuguesa y las traducciones de las explicaciones de datos y correcciones."},{"at":"2026-10-07T05:57:01+03:00","language":"es","text":"Se añadió la clasificación de los datos: cada cifra lleva ahora un identificador de medida con su unidad, geografía, frecuencia y tipo. No cambió ninguna cifra, unidad ni fecha."}],"country":"BR","data":{"blocks":[{"description":{"ar":"النتائج والتمويل الواردان في إعلان وزارة الصحة بتاريخ 2 أكتوبر.","de":"Ergebnisse und Mittelzuweisungen aus der Mitteilung des Gesundheitsministeriums vom 2. Oktober.","en":"Outcomes and allocations stated in the Health Ministry’s October 2 notice.","es":"Resultados y asignaciones indicados en el anuncio ministerial del 2 de octubre.","fr":"Résultats et allocations indiqués dans l’annonce du ministère le 2 octobre.","pt":"Resultados e recursos alocados conforme comunicado do Ministério da Saúde de 2 de outubro.","tr":"Sağlık Bakanlığının 2 Ekim duyurusunda belirtilen sonuç ve kaynaklar."},"id":"brazil-immunoglobulin-agreement-data","items":[{"basis":"estimate","label":{"ar":"الزيادة المتوقعة في السعة","de":"Erwarteter Kapazitätszuwachs","en":"Capacity increase expected","es":"Aumento de capacidad previsto","fr":"Hausse de capacité attendue","pt":"Aumento de capacidade esperado","tr":"Beklenen kapasite artışı"},"measure":{"aggregation":"change","frequency":"irregular","geography":"brazil","id":"brazil-hemobras-immunoglobulin-capacity-increase","periodRole":"announcement-date","unitCode":"percent"},"period":"2026-10-02","unit":"%","value":30.0,"valueQualifier":"approximate"},{"basis":"observed","label":{"ar":"التمويل المخصص لخدمات مراكز الدم","de":"Zugewiesene Mittel für Blutzelldienste","en":"Blood-center service funding allocated","es":"Financiación asignada a centros de sangre","fr":"Financement alloué aux centres sanguins","pt":"Recursos destinados aos serviços de hemocentros","tr":"Hemocenter hizmetleri için ayrılan kaynak"},"measure":{"aggregation":"stock","frequency":"irregular","geography":"brazil","id":"brazil-blood-center-service-funding","periodRole":"announcement-date","unitCode":"million-brl"},"period":"2026-10-02","unit":"million BRL","value":38},{"basis":"observed","label":{"ar":"المعدات الموزعة","de":"Verteilte Ausrüstung","en":"Equipment distributed","es":"Equipos distribuidos","fr":"Équipements distribués","pt":"Equipamentos distribuídos","tr":"Dağıtılan ekipman"},"measure":{"aggregation":"stock","frequency":"irregular","geography":"brazil","id":"brazil-blood-center-equipment-distributed","periodRole":"announcement-date","unitCode":"count"},"period":"2026-10-02","unit":"count","value":604},{"basis":"observed","label":{"ar":"الخدمات التي تلقت المعدات","de":"Dienste mit erhaltener Ausrüstung","en":"Services receiving equipment","es":"Servicios que recibieron equipos","fr":"Services ayant reçu des équipements","pt":"Serviços que receberam equipamentos","tr":"Ekipman alan hizmet birimi"},"measure":{"aggregation":"stock","frequency":"irregular","geography":"brazil","id":"brazil-blood-center-services-equipped","periodRole":"announcement-date","unitCode":"count"},"period":"2026-10-02","unit":"count","value":125}],"methodology":{"ar":"نسبة 30% سعة متوقعة تقريبية؛ والتمويل والمعدات والخدمات إجماليات إدارية أبلغت عنها الوزارة.","de":"Die rund 30 Prozent beziehen sich auf die erwartete Kapazität; Finanzierung, Ausrüstung und erfasste Dienste sind vom Ministerium gemeldete Verwaltungszahlen.","en":"The approximate 30% is expected capacity; funding, equipment and service coverage are administrative totals reported by the ministry.","es":"El 30% es una capacidad prevista aproximada; la financiación, equipos y servicios son totales administrativos informados por el ministerio.","fr":"Les 30 % représentent une capacité attendue approximative ; les financements, équipements et services sont des totaux administratifs communiqués par le ministère.","pt":"Os cerca de 30% referem-se à capacidade esperada; financiamento, equipamentos e serviços cobertos são totais administrativos informados pelo ministério.","tr":"Yaklaşık yüzde 30 artış beklenen kapasitedir; ödenek, dağıtılan ekipman ve hizmet kapsamı bakanlığın bildirdiği idari toplamdır."},"sourceUrls":["https://www.gov.br/saude/pt-br/assuntos/noticias-ms/2026/outubro/brasil-firma-acordo-para-ampliar-producao-de-imunoglobulina-medicamento-para-doencas-do-sangue/"],"title":{"ar":"استثمار مراكز الدم وقدرتها","de":"Investitionen und Kapazität von Blutzentren","en":"Blood-center investment and capacity","es":"Inversión y capacidad de centros de sangre","fr":"Investissement et capacité des centres sanguins","pt":"Investimento e capacidade de hemocentros","tr":"Hemocenter yatırımı ve kapasite"},"type":"metrics","updatedAt":"2026-10-07T00:51:14+03:00"}],"version":1},"data_downloads":[{"formats":{"csv":"https://newsverum.com/api/v1/articles/brazil-hemobras-immunoglobulin-supply-agreement-october-2026/data/brazil-immunoglobulin-agreement-data?lang=es&format=csv","json":"https://newsverum.com/api/v1/articles/brazil-hemobras-immunoglobulin-supply-agreement-october-2026/data/brazil-immunoglobulin-agreement-data?lang=es&format=json"},"id":"brazil-immunoglobulin-agreement-data"}],"data_types":["metrics"],"editorial_illustration":{"alt":"Ilustración conceptual de salud pública, investigación y datos conectados.","asset_id":"newsverum-v1-health","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.avif","width":1536}],"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"es","scope":"topic","url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","width":1536}],"width":1536},"event_id":"event-0ffced43-7698-5eba-a00e-d2a78030ca83","event_period":"2026-10-02","event_period_basis":"event-or-reference-period","id":"brazil-hemobras-immunoglobulin-supply-agreement-october-2026","image":null,"importance":0.6,"language":"es","modified_at":"2026-10-07T05:57:01+03:00","publication_basis":"publication-record","published_at":"2026-10-06T17:11:49+00:00","reading_minutes":1,"region":"world","section_illustration":{"alt":"Ilustración conceptual de salud pública, investigación y datos conectados.","asset_id":"newsverum-v1-health","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.avif","width":1536}],"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"es","scope":"section","url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","width":1536}],"width":1536},"slug":"brazil-hemobras-immunoglobulin-supply-agreement-october-2026","sources":[{"checkedAt":"2026-10-06","name":"Ministry of Health of Brazil","publishedAt":"2026-10-02","url":"https://www.gov.br/saude/pt-br/assuntos/noticias-ms/2026/outubro/brasil-firma-acordo-para-ampliar-producao-de-imunoglobulina-medicamento-para-doencas-do-sangue/"}],"summary":"La cooperación entre Hemobrás y Tiantan Bio abarca el suministro del medicamento derivado del plasma y una posible transferencia tecnológica.","text":"La cooperación entre Hemobrás y Tiantan Bio abarca el suministro del medicamento derivado del plasma y una posible transferencia tecnológica.\n\nEl Ministerio de Salud de Brasil informó que Hemobrás y la empresa china Tiantan Bio firmaron un acuerdo de cooperación en São Paulo el 2 de octubre para ampliar las fuentes de suministro de inmunoglobulina. Según el ministerio, el acuerdo establece un marco para el registro en Brasil, el suministro de inmunoglobulina humana intravenosa y la concesión y transferencia de tecnología.\n\nLos detalles del suministro y de la tecnología se definirán en acuerdos separados y estarán sujetos a los requisitos de Anvisa. El ministerio también dijo que la modernización de equipos podría aumentar cerca de un 30% la capacidad de almacenamiento de plasma; se distribuyeron 604 equipos a 125 servicios de hemoterapia y se asignaron 38 millones de reales para mejorar los centros de sangre.\n\nSe añadieron a este artículo las ediciones alemana y portuguesa y las traducciones de las explicaciones de datos y correcciones.\n\nSe añadió la clasificación de los datos: cada cifra lleva ahora un identificador de medida con su unidad, geografía, frecuencia y tipo. No cambió ninguna cifra, unidad ni fecha.","title":"Brasil firma un acuerdo para ampliar el suministro de inmunoglobulina","topics":[],"translations":[{"api_url":"https://newsverum.com/api/v1/articles/brazil-hemobras-immunoglobulin-supply-agreement-october-2026?lang=tr","language":"tr","url":"https://newsverum.com/tr/news/brazil-hemobras-immunoglobulin-supply-agreement-october-2026"},{"api_url":"https://newsverum.com/api/v1/articles/brazil-hemobras-immunoglobulin-supply-agreement-october-2026?lang=en","language":"en","url":"https://newsverum.com/en/news/brazil-hemobras-immunoglobulin-supply-agreement-october-2026"},{"api_url":"https://newsverum.com/api/v1/articles/brazil-hemobras-immunoglobulin-supply-agreement-october-2026?lang=ar","language":"ar","url":"https://newsverum.com/ar/news/brazil-hemobras-immunoglobulin-supply-agreement-october-2026"},{"api_url":"https://newsverum.com/api/v1/articles/brazil-hemobras-immunoglobulin-supply-agreement-october-2026?lang=fr","language":"fr","url":"https://newsverum.com/fr/news/brazil-hemobras-immunoglobulin-supply-agreement-october-2026"},{"api_url":"https://newsverum.com/api/v1/articles/brazil-hemobras-immunoglobulin-supply-agreement-october-2026?lang=es","language":"es","url":"https://newsverum.com/es/news/brazil-hemobras-immunoglobulin-supply-agreement-october-2026"},{"api_url":"https://newsverum.com/api/v1/articles/brazil-hemobras-immunoglobulin-supply-agreement-october-2026?lang=de","language":"de","url":"https://newsverum.com/de/news/brazil-hemobras-immunoglobulin-supply-agreement-october-2026"},{"api_url":"https://newsverum.com/api/v1/articles/brazil-hemobras-immunoglobulin-supply-agreement-october-2026?lang=pt","language":"pt","url":"https://newsverum.com/pt/news/brazil-hemobras-immunoglobulin-supply-agreement-october-2026"}],"url":"https://newsverum.com/es/news/brazil-hemobras-immunoglobulin-supply-agreement-october-2026"},"version":"1"}